Common use of Certain Obligations Respecting Subsidiaries Clause in Contracts

Certain Obligations Respecting Subsidiaries. Further Assurances 56 8.13 Termination of Non-Permitted Liens 58 8.14 Intellectual Property 58 8.15 [Reserved]. 58 8.16 Post-Closing Items 58 SECTION 9 NEGATIVE COVENANTS 58 9.01 Indebtedness 58 9.02 Liens 60 9.03 Fundamental Changes and Acquisitions 61 9.04 Lines of Business 61 9.05 Investments 62 9.06 Restricted Payments 63 CONFIDENTIAL TREATMENT REQUESTED UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION. TABLE OF CONTENTS (continued) Page 9.07 Payments of Indebtedness 63 9.08 Change in Fiscal Year 63 9.09 Sales of Assets, Etc 63 9.10 Transactions with Affiliates 64 9.11 Restrictive Agreements 65 9.12 Amendments to Material Agreements; Organizational Documents 65 9.13 Operating Leases 65 9.14 Sales and Leasebacks 65 9.15 Hazardous Material 65 9.16 Accounting Changes 65 9.17 Compliance with ERISA 65 9.18 Swedish Borrower 66 SECTION 10 FINANCIAL COVENANTS 66 10.01 Minimum Liquidity 66 10.02 Minimum Revenue 66 10.03 Cure Right 66 SECTION 11 EVENTS OF DEFAULT 67 11.01 Events of Default 67 11.02 Remedies 70 SECTION 12 ADMINISTRATIVE AGENT 71 12.01 Appointment and Duties 71 12.02 Binding Effect 73 12.03 Use of Discretion 73 12.04 Delegation of Rights and Duties 73 12.05 Reliance and Liability 73 12.06 Administrative Agent Individually 74 CONFIDENTIAL TREATMENT REQUESTED UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION. TABLE OF CONTENTS (continued) Page 12.07 Lender Credit Decision 74 12.08 Expenses; Indemnities 75 12.09 Resignation of Administrative Agent 75 12.10 Release of Collateral or Guarantors 76 12.11 Release of Swedish Liens 77 12.12 Automatic Releases of Obligors and Liens (other than Swedish Liens). 77 SECTION 13 MISCELLANEOUS 77 13.01 No Waiver 77 13.02 Notices 78 13.03 Expenses, Indemnification, Etc 78 13.04 Amendments, Etc 79 13.05 Successors and Assigns 80 13.06 Survival 82 13.07 Captions 82 13.08 Counterparts 82 13.09 Governing Law 82 13.10 Jurisdiction, Service of Process and Venue 82

Appears in 1 contract

Samples: Term Loan Agreement (Strongbridge Biopharma PLC)

AutoNDA by SimpleDocs

Certain Obligations Respecting Subsidiaries. Further Assurances 56 8.13 5658 Section 8.13. Termination of Non-Permitted Liens 58 8.14 5659 Section 8.14. Intellectual Property 58 8.15 [Reserved]5759 Section 8.15. 58 8.16 ERISA Compliance 5759 Section 8.16. Cash Management 5759 Section 8.17. Post-Closing Items 58 SECTION 9 NEGATIVE COVENANTS 58 9.01 Obligations 5720 Section 8.18. Milestone. 5720 Section 8.19. Icagen-T Lien 5720 Section 8.20. Board Observer Rights 5820 Section 8.21. Cash Flow 21 Section 8.22. Sanofi Agreement 21 Section 8.23. Tuscon Real Estate 21 Section 8.24. Series C Capital Raise 21 Section 8.25. Subordinated Notes 21 Section 9. Negative Covenants 5821 Section 9.01. Indebtedness 58 9.02 5821 Section 9.02. Liens 60 9.03 6022 Section 9.03. Fundamental Changes and Acquisitions 61 9.04 6265 Section 9.04. Lines of Business 61 9.05 6365 Section 9.05. Investments 62 9.06 6366 Section 9.06. Restricted Payments 63 CONFIDENTIAL TREATMENT REQUESTED UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.4066467 Section 9.07. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION. TABLE OF CONTENTS (continued) Page 9.07 Payments of Indebtedness 63 9.08 6568 Section 9.08. Change in Fiscal Year 63 9.09 6568 Section 9.09. Sales of Assets, Etc 63 9.10 6568 Section 9.10. Transactions with Affiliates 64 9.11 6669 Section 9.11. Restrictive Agreements 65 9.12 Amendments to 6669 Section 9.12. Modifications and Terminations of Material Agreements; Organizational Agreements and Organic Documents 65 9.13 Operating Leases 65 9.14 6769 Section 9.13. Licensing of Intellectual Property 6770 Section 9.14. Sales and Leasebacks 65 9.15 6770 Section 9.15. Hazardous Material 65 9.16 6770 Section 9.16. Accounting Changes 65 9.17 6770 Section 9.17. Compliance with ERISA 65 9.18 Swedish Borrower 66 SECTION 10 FINANCIAL COVENANTS 66 10.01 Minimum Liquidity 66 10.02 Minimum Revenue 66 10.03 Cure Right 66 SECTION 11 EVENTS OF DEFAULT 67 11.01 Events of Default 67 11.02 Remedies 70 SECTION 12 ADMINISTRATIVE AGENT 71 12.01 Appointment and Duties 71 12.02 Binding Effect 73 12.03 Use of Discretion 73 12.04 Delegation of Rights and Duties 73 12.05 Reliance and Liability 73 12.06 Administrative Agent Individually 74 CONFIDENTIAL TREATMENT REQUESTED UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION. TABLE OF CONTENTS (continued) Page 12.07 Lender Credit Decision 74 12.08 Expenses; Indemnities 75 12.09 Resignation of Administrative Agent 75 12.10 Release of Collateral or Guarantors 76 12.11 Release of Swedish Liens 77 12.12 Automatic Releases of Obligors and Liens (other than Swedish Liens). 77 SECTION 13 MISCELLANEOUS 77 13.01 No Waiver 77 13.02 Notices 78 13.03 Expenses, Indemnification, Etc 78 13.04 Amendments, Etc 79 13.05 Successors and Assigns 80 13.06 Survival 82 13.07 Captions 82 13.08 Counterparts 82 13.09 Governing Law 82 13.10 Jurisdiction, Service of Process and Venue 826770

Appears in 1 contract

Samples: Forbearance Agreement (Icagen, Inc.)

Certain Obligations Respecting Subsidiaries. Further Assurances 56 8.13 76 Section 8.12. Termination of Non-Permitted Liens 58 8.14 Intellectual Property 58 8.15 77 Section 8.13. [Reserved]] 77 Section 8.14. 58 8.16 Anti-Terrorism and Anti-Corruption Laws 77 Section 8.15. Minimum Liquidity 78 Section 8.16. Minimum Total Revenue 78 Section 8.17. Maintenance of Regulatory Approvals, Contracts, Intellectual Property, Etc. 79 Section 8.18. Cash Management 79 Section 8.19. Certain Post-Closing Items 58 SECTION Funding Obligations 80 Article 9 NEGATIVE COVENANTS 58 9.01 Negative Covenants 80 Section 9.01. Indebtedness 58 9.02 80 Section 9.02. Liens 60 9.03 82 -ii- Section 9.03. Fundamental Changes and Acquisitions 61 9.04 84 Section 9.04. Lines of Business 61 9.05 85 Section 9.05. Investments 62 9.06 85 Section 9.06. Restricted Payments 63 CONFIDENTIAL TREATMENT REQUESTED UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.40687 Section 9.07. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION. TABLE OF CONTENTS (continued) Page 9.07 Payments of Indebtedness 63 9.08 87 Section 9.08. Change in Fiscal Year 63 9.09 87 Section 9.09. Sales of Assets, Etc 63 9.10 88 Section 9.10. Transactions with Affiliates 64 9.11 89 Section 9.11. Restrictive Agreements 65 9.12 Amendments to 90 Section 9.12. Organizational Documents, Material Agreements; Organizational Documents 65 9.13 Operating Leases 65 9.14 Agreements 90 Section 9.13. Holding Company 91 Section 9.14. Sales and Leasebacks 65 9.15 91 Section 9.15. Hazardous Material 65 9.16 91 Section 9.16. Accounting Changes 65 9.17 91 Section 9.17. Compliance with ERISA 65 9.18 Swedish Borrower 66 SECTION 91 Section 9.18. Deposit Accounts 92 Section 9.19. Outbound Licenses 92 Section 9.20. Inbound Licenses 92 Article 10 FINANCIAL COVENANTS 66 10.01 Minimum Liquidity 66 10.02 Minimum Revenue 66 10.03 Cure Right 66 SECTION 11 EVENTS OF DEFAULT 67 11.01 Events of Default 67 11.02 92 Section 10.01. Events of Default 92 Section 10.02. Remedies 70 SECTION 95 Section 10.03. Prepayment Premium and Redemption Price 96 Article 11 Guarantee 96 Section 11.01. The Guarantee 96 Section 11.02. Obligations Unconditional 97 Section 11.03. Reinstatement 98 Section 11.04. Subrogation 99 Section 11.05. Remedies 99 Section 11.06. Instrument for the Payment of Money 99 Section 11.07. Continuing Guarantee 99 Section 11.08. Rights of Contribution 100 Section 11.09. General Limitation on Guarantee Obligations 100 Article 12 ADMINISTRATIVE AGENT 71 12.01 Administrative Agent 101 Section 12.01. Appointment and Duties 71 12.02 Binding Effect 73 12.03 Use of Discretion 73 12.04 101 Section 12.02. Rights as a Lender 101 Section 12.03. Exculpatory Provisions 101 Section 12.04. Reliance by Administrative Agent 102 Section 12.05. Delegation of Rights and Duties 73 12.05 103 Section 12.06. Resignation of Agent 103 Section 12.07. Non-Reliance and Liability 73 12.06 on Administrative Agent Individually 74 CONFIDENTIAL TREATMENT REQUESTED UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406and Other Lenders 104 Section 12.08. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION. TABLE OF CONTENTS (continued) Page 12.07 Lender Credit Decision 74 12.08 Expenses; Indemnities 75 12.09 Resignation of Administrative Agent 75 12.10 Release May File Proofs of Collateral or Guarantors 76 12.11 Release of Swedish Liens 77 12.12 Automatic Releases of Obligors and Liens (other than Swedish Liens). 77 SECTION 13 MISCELLANEOUS 77 13.01 No Waiver 77 13.02 Notices 78 13.03 Expenses, Indemnification, Etc 78 13.04 Amendments, Etc 79 13.05 Successors and Assigns 80 13.06 Survival 82 13.07 Captions 82 13.08 Counterparts 82 13.09 Governing Law 82 13.10 Jurisdiction, Service of Process and Venue 82Claim 104

Appears in 1 contract

Samples: Credit Agreement (GeneDx Holdings Corp.)

Certain Obligations Respecting Subsidiaries. Further Assurances 56 8.13 60 Section 8.13. Termination of Non-Permitted Liens 58 8.14 60 Section 8.14. Intellectual Property 58 8.15 [Reserved]61 Section 8.15. 58 8.16 ERISA Compliance 61 Section 8.16. Cash Management 61 Section 8.17. Post-Closing Items 58 SECTION 9 NEGATIVE COVENANTS 58 9.01 Obligations 61 Section 8.18. Milestone 61 Section 8.19. Icagen-T Lien 62 Section 8.20. Board Observer Rights 62 Section 8.21. Cash Flow 62 Section 8.22. Sanofi Agreement 62 Section 8.23. Tucson Real Estate 62 Section 8.24. Series C Capital Raise 62 Section 8.25. Subordinated Notes 63 Section 8.26. Real Estate Broker 63 Section 8.27. Sale of North Carolina Business 63 Section 8.28. Amendment to Mortgage 63 Section 9. Negative Covenants 63 Section 9.01. Indebtedness 58 9.02 63 Section 9.02. Liens 60 9.03 65 Section 9.03. Fundamental Changes and Acquisitions 61 9.04 67 Section 9.04. Lines of Business 61 9.05 68 Section 9.05. Investments 62 9.06 68 Section 9.06. Restricted Payments 63 CONFIDENTIAL TREATMENT REQUESTED UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.40669 Section 9.07. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION. TABLE OF CONTENTS (continued) Page 9.07 Payments of Indebtedness 63 9.08 70 Section 9.08. Change in Fiscal Year 63 9.09 70 Section 9.09. Sales of Assets, Etc 63 9.10 70 Section 9.10. Transactions with Affiliates 64 9.11 71 Section 9.11. Restrictive Agreements 65 9.12 Amendments to 71 Section 9.12. Modifications and Terminations of Material Agreements; Organizational Agreements and Organic Documents 65 9.13 Operating Leases 65 9.14 72 Section 9.13. Licensing of Intellectual Property 72 Section 9.14. Sales and Leasebacks 65 9.15 72 Section 9.15. Hazardous Material 65 9.16 72 Section 9.16. Accounting Changes 65 9.17 72 Section 9.17. Compliance with ERISA 65 9.18 Swedish Borrower 66 SECTION 10 FINANCIAL COVENANTS 66 10.01 72 Section 10. Financial Covenants 72 Section 10.01. Minimum Liquidity 66 10.02 72 Section 10.02. Minimum Revenue 66 10.03 Cure Right 66 SECTION 11 EVENTS OF DEFAULT 67 11.01 73 Section 11. Events of Default 67 11.02 73 Section 11.01. Events of Default 73 Section 11.02. Remedies 70 SECTION 12 ADMINISTRATIVE AGENT 71 12.01 76 Section 11.03. Additional Remedies 76 Section 11.04. Prepayment Premium and Redemption Price 77 Section 12. Guarantee 77 Section 12.01. The Guarantee 77 Section 12.02. Obligations Unconditional 78 Section 12.03. Reinstatement 78 Section 12.04. Subrogation 79 Section 12.05. Remedies 79 Section 12.06. Instrument for the Payment of Money 79 Section 12.07. Continuing Guarantee 79 Section 12.08. Rights of Contribution 79 Section 12.09. General Limitation on Guarantee Obligations 80 Section 13. Administrative Agent 80 Section 13.01. Appointment and Duties 71 12.02 Binding Effect 73 12.03 Use of Discretion 73 12.04 80 Section 13.02. Rights as a Lender 81 Section 13.03. Exculpatory Provisions 81 Section 13.04. Reliance by Administrative Agent 82 Section 13.05. Delegation of Rights and Duties 73 12.05 82 Section 13.06. Resignation of Agent 83 Section 13.07. Non-Reliance and Liability 73 12.06 on Administrative Agent Individually 74 CONFIDENTIAL TREATMENT REQUESTED UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406and Other Lenders 83 Section 13.08. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION. TABLE OF CONTENTS (continued) Page 12.07 Lender Credit Decision 74 12.08 Expenses; Indemnities 75 12.09 Resignation of Administrative Agent 75 12.10 Release May File Proofs of Claim 84 Section 13.09. Collateral and Guaranty Matters; Appointment of Collateral or Guarantors 76 12.11 Release of Swedish Liens 77 12.12 Automatic Releases of Obligors and Liens (other than Swedish Liens)Agent 84 Section 14. 77 SECTION 13 MISCELLANEOUS 77 13.01 Miscellaneous 85 Section 14.01. No Waiver 77 13.02 85 Section 14.02. Notices 78 13.03 85 Section 14.03. Expenses, Indemnification, Etc 78 13.04 Etc. 86 Section 14.04. Amendments, Etc 79 13.05 Etc. 87 Section 14.05. Successors and Assigns 80 13.06 87 Section 14.06. Survival 82 13.07 89 Section 14.07. Captions 82 13.08 89 Section 14.08. Counterparts 82 13.09 89 Section 14.09. Governing Law 82 13.10 90 Section 14.10. Jurisdiction, Service of Process and Venue 8290 Section 14.11. Waiver of Jury Trial 90 Section 14.12. Waiver of Immunity 90 Section 14.13. Entire Agreement 91 Section 14.14. Severability 91 Section 14.15. No Fiduciary Relationship 91 Section 14.16. Confidentiality 91 Section 14.17. Right of Setoff 92 Section 14.18. Judgment Currency 92 Section 14.19. USA PATRIOT Act 93 Section 14.20. Release of Collateral and Guarantees; Non-Disturbance Agreements 93 Section 14.21. Acknowledgement and Consent to Bail-In of EEA Financial Institutions 93 Schedules and Exhibits Schedule 1 — Commitments and Warrant Shares Schedule 7.05(b) — Obligor Intellectual Property Schedule 7.05(c) — Material Intellectual Property Schedule 7.06(a) — Certain Litigation Schedule 7.06(c) — Labor Matters Schedule 7.08 — Taxes Schedule 7.12(a) — Equity Holders Schedule 7.12(b) — Information Regarding Subsidiaries Schedule 7.12(c) — Equity Investments Schedule 7.13(a) — Outstanding Indebtedness Schedule 7.13(b) — Pay-Off Indebtedness Schedule 7.13(c) — Liens Schedule 7.14 — Material Agreements of Obligors Schedule 7.15 — Restrictive Agreements Schedule 7.16 — Real Property Owned or Leased by Obligors or any Subsidiary Schedule 7.17 — Pension Matters Schedule 7.19(b) — Regulatory Approvals Schedule 7.19(e) — Certain Regulatory Matters Schedule 7.20 — Transactions with Affiliates Schedule 7.21 — OFAC Matters Schedule 7.23 — Deposit and Disbursement Accounts Schedule 7.24 — Royalty and Payments Schedule 8.17 — Post-Closing Obligations Schedule 9.05 — Existing Investments Schedule 9.10 — Transactions with Affiliates Schedule 9.14 — Permitted Sales and Leasebacks Schedule 10.02 — Contemplated Collaboration Agreement Exhibit a — Form of Note Exhibit b — [Reserved] Exhibit c — Form of Guarantee Assumption Agreement Exhibit d-1 — Forms of U.S. Tax Compliance Certificate Exhibit d-2 — Forms of U.S. Tax Compliance Certificate Exhibit d-3 — Forms of U.S. Tax Compliance Certificate Exhibit d-4 — Forms of U.S. Tax Compliance Certificate Exhibit e — Form of Compliance Certificate Exhibit f — Form of Assignment and Assumption Exhibit g — Form of Landlord Consent Exhibit h — Form of Security Agreement Exhibit i — Form of Collateral Questionnaire Exhibit j — Form of Patent Security Agreement Exhibit k — Form of Trademark Security Agreement Exhibit l — Form of Copyright Security Agreement Exhibit m — Form of Closing Date Certificate Credit Agreement and Guaranty Credit Agreement and Guaranty, dated as of August 31, 2018 (this “Agreement”), among Icagen-T, Inc., a Delaware corporation (the “Borrower”), Icagen, Inc., a Delaware corporation (“Parent”), certain of Parent’s Subsidiaries from time to time parties hereto, the lenders from time to time party hereto (each, a “Lender” and collectively, the “Lenders”), and Perceptive Credit Holdings II, LP, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

Appears in 1 contract

Samples: Forbearance Agreement (Icagen, Inc.)

AutoNDA by SimpleDocs

Certain Obligations Respecting Subsidiaries. Further Assurances 56 8.13 Section 8.12. Termination of Non-Permitted Liens 57 Section 8.13. Non-Consolidation 58 8.14 Intellectual Property Section 8.14. Anti-Terrorism and Anti-Corruption Laws 58 8.15 [Reserved]Section 8.15. Milestone 58 8.16 Post-Closing Items Section 8.16. Minimum Liquidity 58 SECTION 9 Section 8.17. Accounts 58 ARTICLE 9. NEGATIVE COVENANTS 58 9.01 59 Section 9.01. Indebtedness 58 9.02 59 Section 9.02. Liens 60 9.03 Section 9.03. Fundamental Changes and Acquisitions 61 9.04 Section 9.04. Lines of Business 61 9.05 62 Section 9.05. Investments 62 9.06 Section 9.06. Restricted Payments 63 CONFIDENTIAL TREATMENT REQUESTED UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406Section 9.07. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION. TABLE OF CONTENTS (continued) Page 9.07 Payments of Indebtedness 63 9.08 64 Section 9.08. Change in Fiscal Year 63 9.09 64 Section 9.09. Sales of Assets, Etc 63 9.10 Etc. 64 Section 9.10. Transactions with Affiliates 64 9.11 65 Section 9.11. Restrictive Agreements 65 9.12 Amendments to 66 Section 9.12. Organizational Documents, Material Agreements; Organizational Documents 65 9.13 Operating Leases 65 9.14 Agreements 66 Section 9.13. [Reserved] 66 Section 9.14. Sales and Leasebacks 65 9.15 66 Section 9.15. Hazardous Material 65 9.16 67 Section 9.16. Accounting Changes 65 9.17 67 Section 9.17. Compliance with ERISA 65 9.18 Swedish Borrower 66 SECTION 10 FINANCIAL COVENANTS 66 10.01 Minimum Liquidity 66 10.02 Minimum Revenue 66 10.03 Cure Right 66 SECTION 11 67 ARTICLE 10. EVENTS OF DEFAULT 67 11.01 Section 10.01. Events of Default 67 11.02 Section 10.02. Remedies 70 SECTION 12 ADMINISTRATIVE AGENT Section 10.03. Exit Fee, Prepayment Premium and Redemption Price 71 12.01 Appointment and Duties ARTICLE 11. GUARANTEE 71 12.02 Binding Effect Section 11.01. The Guarantee 71 Section 11.02. Obligations Unconditional 72 Section 11.03. Reinstatement 73 12.03 Use Section 11.04. Subrogation 73 Section 11.05. Remedies 73 Section 11.06. Instrument for the Payment of Discretion Money 73 12.04 Delegation Section 11.07. Continuing Guarantee 73 Section 11.08. Rights of Rights and Duties 73 12.05 Reliance and Liability 73 12.06 Administrative Agent Individually Contribution 74 CONFIDENTIAL TREATMENT REQUESTED UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406Section 11.09. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSIONGeneral Limitation on Guarantee Obligations 74 ARTICLE 12. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSIONRESERVED 75 ARTICLE 13. TABLE OF CONTENTS (continued) Page 12.07 Lender Credit Decision 74 12.08 Expenses; Indemnities MISCELLANEOUS 75 12.09 Resignation of Administrative Agent 75 12.10 Release of Collateral or Guarantors 76 12.11 Release of Swedish Liens 77 12.12 Automatic Releases of Obligors and Liens (other than Swedish Liens)Section 13.01. 77 SECTION 13 MISCELLANEOUS 77 13.01 No Waiver 77 13.02 75 Section 13.02. Notices 78 13.03 Expenses, Indemnification, Etc 78 13.04 Amendments, Etc 79 13.05 Successors and Assigns 80 13.06 Survival 82 13.07 Captions 82 13.08 Counterparts 82 13.09 Governing Law 82 13.10 Jurisdiction, Service of Process and Venue 8275

Appears in 1 contract

Samples: Credit Agreement (Molecular Templates, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.